Skip to main content
. 2023 Jan 31;15(3):877. doi: 10.3390/cancers15030877

Figure 3.

Figure 3

First and second panel: Protein expression of MITF with HSP90 as loading control under the untreated, DMSO, 0.1 µM anisomycin for 30 min, and 0.1 µM anisomycin for 24 h treatment conditions in cell lines 134029 and 160915. Third and fourth panel: Protein expression of MITF with HSP90 as loading control under the untreated, DMSO, and 0.1 µM anisomycin for 30 min treatment conditions in cell lines EV control–130429/160915 and p38–130429/160915.